Printer Friendly

Browse Mechcatie, Elizabeth

1-300 out of 705 article(s) nextnext page
Title Type Date Words
When to consider systemic exposure in patients with contact dermatitis. Brief article Oct 15, 2017 273
Wound-healing Tx approved for diabetic foot ulcers. Feb 1, 2016 340
FDA approves alirocumab for hypercholesterolemia: the injectable biologic's wholesale acquisition cost will be $40 per day, or $14,600 per year. Aug 1, 2015 764
Pro's and con's of prenatal cell-free DNA testing. Aug 1, 2015 756
ACIP: Give MenB vaccine to teens, college students: these are category B recommendations, meaning compliance is optional. Jul 1, 2015 780
Biologic lipid-lowering alirocumab wows panel. Jul 1, 2015 810
Alogliptin CV risk acceptable, experts agree. May 1, 2015 639
Panel reassured by saxagliptin's CV safety data. May 1, 2015 586
Panel backs once-daily ICS/LABA combo for adults. Apr 15, 2015 790
FDA: avoid using amiodarone with some Hep C antivirals. Apr 15, 2015 403
FDA focuses on infections with reusable devices. Apr 1, 2015 588
ACIP votes to drop preference for LAIV in healthy kids. Brief article Mar 15, 2015 246
ACIP: Use MenB vaccine during college outbreaks. Mar 15, 2015 797
Cannabis is teens' 'drug of choice' in bipolar disorder. Mar 1, 2015 1152
Stimulant is approved for binge-eating disorder. Report Feb 15, 2015 336
FDA approves vagal-blocking device. Feb 1, 2015 619
NIH: data needed to guide long-term opioid therapy. Clinical report Feb 1, 2015 1015
FDA approves hydrocodone with abuse deterrent formula. Dec 1, 2014 490
FDA addresses neurologic risks of epidural steroids. Dec 1, 2014 634
'Lay' naloxone for patients on opioids may save lives. Oct 15, 2014 783
FDA approves drug for opioid-induced constipation. Oct 1, 2014 324
Empagliflozin okayed for type 2 diabetes. Brief article Aug 1, 2014 287
FDA approves implantable tongue stimulator for apnea. Jun 15, 2014 302
One in 10 heart attack patients has unrecognized diabetes. Report Jun 15, 2014 310
Empagliflozin improves glycemia, blood pressure. Jun 1, 2014 622
Phase III data: canagliflozin effects include weight loss. Clinical report Jun 1, 2014 453
FDA panel not convinced of opiate combo safety. May 1, 2014 563
Panel backs inhaled insulin for types 1, 2 diabetes. Apr 15, 2014 929
Fruit, vegetable intake linked to future benefits. Apr 1, 2014 661
Women's cardiac risk rises with more live births. Apr 1, 2014 453
FDA panel backs cobas HPV test as primary screening tool. Apr 1, 2014 853
Endoscopically placed obesity devices on the horizon. Mar 15, 2014 985
Prenatal acetaminophen exposure may up ADHD risk. Mar 1, 2014 617
Continuous glucose monitor approved for ages 2-17. Feb 15, 2014 521
Assay to help diagnose developmental delay gets okay. Brief article Feb 1, 2014 290
Obesity as a disease: implications for treatment, pay. Feb 1, 2014 722
Vorapaxar gets a thumbs up from FDA panel. Feb 1, 2014 448
Second SGLT2 inhibitor dapagliflozin approved for type 2 diabetes. Jan 1, 2014 1098
Guidelines focus on lifestyle management, obesity. Dec 1, 2013 547
FDA lifts rosiglitazone prescribing restrictions. Dec 1, 2013 497
Panel urges approval of antiviral for chronic HCV. Nov 15, 2013 926
FDA moves to lower or banish trans fats from foods. Brief article Nov 15, 2013 282
Chest x-rays for asthma doubled in 15 years. Sep 15, 2013 331
Task force backs primary care intervention on tobacco. Sep 1, 2013 375
Rosiglitazone may not up heart risk in CAD patients. Aug 1, 2013 1060
Villous atrophy in celiac disease linked to cancer risk. Aug 1, 2013 448
Roche halts studies of experimental type 2 DM drug. Jul 1, 2013 391
FDA panel supports easing or lifting rosiglitazone safety restrictions: advice is based on reanalysis of existing safety data. Jun 15, 2013 857
Agency approved two more drugs for advanced melanoma. Jun 15, 2013 508
Familiar respiratory culprits fueled Alabama illnesses. Jun 15, 2013 347
FDA seeks skin cancer warning on tanning lamps. May 15, 2013 606
'Mobility shoes' potentially benefit knee OA. May 1, 2013 679
Advisory panel backs ICS/LABA inhaler for COPD. May 1, 2013 915
Gabapentine deemed ineffective for hot flashes. Conference news Mar 15, 2013 579
New influenza vaccines make list for 2013-2014. Conference news Mar 15, 2013 808
FDA panel picks strains for next season's flu vaccine. Mar 15, 2013 449
CDC committee affirms update of 1993 Hib statement. Mar 15, 2013 531
FDA panel rejects SSRI's approval as hot-flash treatment. Mar 15, 2013 388
IOM: poor-quality drugs are a global problem. Mar 1, 2013 632
ACIP backs routine PCV13 vaccine in high-risk children. Mar 1, 2013 576
FDA withholds insulin degludec approval; wants safety data. Mar 1, 2013 257
Panel votes against inhaled mannitol for CF. Feb 15, 2013 716
Mipomersen approved for familial hypercholesterolemia. Feb 15, 2013 524
FDA issues safety update on metal-on-metal hips. Feb 15, 2013 514
IOM report: children's vaccine schedule found to be safe. Feb 15, 2013 349
Hydrocodone may face more restrictions. Feb 1, 2013 845
Panel backs canagliflozin for type 2 diabetes care. Feb 1, 2013 1227
Abuse potential cited in hydrocodone panel vote. Jan 1, 2013 753
Abiraterone approved for use before prostate cancer chemo. Jan 1, 2013 892
Aspirin 'resistance' connected to enteric coating. Jan 1, 2013 662
Panel backs multidrug-resistant TB treatment: novel mechanism of action boosts drug's effect in MDR-TB, when combined with standard therapy. Dec 1, 2012 753
Panel: safety data needed for hep B vaccine. Dec 1, 2012 725
Lung symptoms vary during menstrual cycle. Dec 1, 2012 634
Tdap vaccine advised during every pregnancy. Nov 15, 2012 590
Rivaroxaban approved for DVT and PE. Brief article Nov 15, 2012 208
Bupropion genetic yanked over bioequivalence. Oct 15, 2012 494
FDA reviewing heart failure risk with dopamine agonist pramipexole. Oct 1, 2012 414
IDSA updates seasonal and pandemic flu preparedness. Oct 1, 2012 375
FDA approves two new strains in 2012 flu vaccine. Sep 1, 2012 212
First generic pioglitazone approved, with HF warning. Sep 1, 2012 288
Combo drug approved for weight loss, with stipulations. Aug 1, 2012 982
FDA reports seizure risk with multiple sclerosis drug. Aug 1, 2012 376
Drug-drug interactions added to hepatitis C drug label. Aug 1, 2012 365
FDA awaits more ARISTOTLE data on apixaban. Brief article Jul 1, 2012 244
Low-dose aspirin use spiked bleeding risk. Jun 15, 2012 1013
CDC proposes one-time hep C test for baby boomers. Jun 1, 2012 546
FDA approves generic forms of clopidogrel: experts consider; is the end of exclusivity for Plavix a boon for patients or payers? Jun 1, 2012 747
FDA announces contraindication for aliskirin. May 1, 2012 550
FDA: OCs with drospirenone may raise blood clot risk. May 1, 2012 459
FDA clarifies warning on SSRI's arrhythmia risk. Apr 15, 2012 352
Panel backs inhaled anticholinergic for COPD. Mar 15, 2012 677
In reversal, FDA panel now endorses obesity drug Qnexa. Mar 15, 2012 572
FDA approves first quadrivalent seasonal flu vaccine. Mar 15, 2012 715
Cancer screening falls short of federal targets. Feb 15, 2012 796
FDA okays long-acting form of diabetes drug exenatide. Feb 15, 2012 323
Vytorin benefit data for CKD added to label. Feb 15, 2012 606
Survey: 20% of U.S. adults report having mental illness. Feb 1, 2012 806
FDA: dronedarone boosts death risk in permanent AF. Jan 1, 2012 436
Pneumonia vaccine approved for age 50 and up. Jan 1, 2012 566
FDA panel reviews VTE risk for some OCs. Jan 1, 2012 534

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters